Ofloxacin Tablet, Film Coated
Product Images NDC 71209-099

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ofloxacin (NDC 71209-099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cont Label 200mg 500s

OFLOXACIN 200 mg tablets, USP, oral film-coated tablets, packaged in a container of 500 tablets. The label includes dosage strength, labeler Cadila Pharmaceuticals Ltd., manufacturing location in Ahmedabad, India, storage instructions, and a barcode. The label also contains a note to dispense with medication guide and warnings to keep out of reach of children.*

FDA Label Image

Cont Label 300mg 500s

Label for Ofloxacin Tablets, USP 300 mg, film-coated oral tablets. The label states the tablet strength, quantity of 500 tablets, and is marked Rx only. It includes storage instructions, manufacturer information for Cadila Pharmaceuticals Limited, and a barcode. The label indicates the container should be a tight, light-resistant container with a child-resistant closure.*

FDA Label Image

Cont Label 400mg 500s

OFLOXACIN tablets, USP 400 mg, film-coated oral tablets by Cadila Pharmaceuticals Limited. The label states the product contains 500 tablets and is prescription only (Rx only). It includes storage instructions and a barcode, with manufacturer details from Gujarat, India.*

FDA Label Image

Ofloxacin-fig1-structure1 (Ofloxacin Fig1 Structure 1)

Chemical structure of ofloxacin, showing a fluorinated quinolone core with a carboxylic acid group and additional nitrogen-containing rings.*

FDA Label Image

Ofloxacin-fig2-graph (Ofloxacin Fig2 Graph)

A line graph showing ofloxacin mean steady-state plasma levels (mcg/mL) over 24 hours on day 5 for 19 subjects. It compares 400 mg oral (PO) and intravenous (IV) doses, with plasma levels peaking around 7 mcg/mL shortly after administration and gradually declining over time.*

FDA Label Image

Ofloxacin-fig3-formula (Ofloxacin Fig3 Formula)

A text panel showing the formula for calculating creatinine clearance in mL/min. The formula is presented as (Weight in kg multiplied by (140 minus age)) divided by (72 times serum creatinine in mg/dL). This is a typical pharmacokinetic calculation reference.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.